Xylem (XYL) is a Industrials company in the Specialty Industrial Machinery industry. It has a market capitalization of $22.44B, a trailing price-to-earnings ratio of 18.0 and a free-cash-flow yield of 3.8%. Over the most recent reported fiscal year, revenue grew 5.5% and free cash flow per share fell 3.6%. Nama's AI scorecard rates it Hold, 5.2 out of 10. On 12-month momentum it ranks in the trailing band of its market.
AI scorecard
Hold · 5.2/10
The sections balance. As of Nov 7, 2026.
Momentum
Trailing · -32.3% over 12 months ex. last
Bottom 20% of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-36.6%
How far the last close sits under the highest price of the past five years.
Market cap
$22.44B
Trailing P/E
18.0
Price / book
2.2
Price / sales
2.5
FCF yield
3.8%
Dividend yield
1.8%
Gross margin
39.8%
Operating margin
16.1%
Net margin
11.9%
Revenue growth (YoY)
+5.5%
Revenue growth (3-yr annual)
+17.8%
EPS growth (YoY)
+18.7%
FCF/share growth (YoY)
-3.6%
Beta
1.0
Exchange
NYSE
Sector
Industrials
Industry
Specialty Industrial Machinery
XYL earnings
Next report: Feb 9, 2027 (Q4 2026, EPS estimate $1.42).
Beat the EPS estimate in 3 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 27, 2026
$1.44
$1.45
-0.7%
$2.20B
Q2 2026
Jul 28, 2026
$1.46
$1.34
+9.0%
$2.34B
Q1 2026
Apr 28, 2026
$1.12
$1.08
+3.7%
$2.12B
Q4 2025
Feb 10, 2026
$1.42
$1.41
+0.7%
$2.40B
XYL analyst price target
Median target $127.00 from 16 analysts, ranging $90.00 – $180.00.
Nama's AI scorecard currently rates Xylem Hold (5.2 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is XYL's P/E ratio?
Xylem trades at a trailing price-to-earnings ratio of 18.0.
When does XYL report earnings?
Xylem's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $1.42.
What is the XYL price target?
The median analyst price target from 16 analysts is $127.00, with a range of $90.00 – $180.00.
Is XYL Shariah compliant?
Nama's AAOIFI-style screen reads Xylem as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.